雌激素受体在肺部疾病中的作用
Carolyn Damilola Ekpruke1, Patricia Silveyra1
1Department of Environmental and Occupational Health, Indiana University Bloomington, IN, USA.
American journal of physiology. Lung cellular and molecular physiology
|December 31, 2025
概括
雌激素受体 (ERα,ERβ,GPER1) 调节肺部健康和疾病,影响炎症和组织重塑. 它们的平衡解释了喘息和COPD等肺部疾病的性别差异.
科学领域:
- 肺部医学和内分泌学.
- 分子和细胞生物学分子和细胞生物学
- 基于性别的疾病差异.
背景情况:
- 肺部疾病表现出明显的性别差异,其分子基础不清楚.
- 通过雌激素受体α (ERα),雌激素受体β (ERβ) 和GPER1起作用的雌激素是肺恒温的关键调节者.
- 这些受体通过基因组和非基因组途径调节炎症,氧化应激和组织重塑.
研究的目的:
- 对肺部疾病中雌激素受体信号传导的机械学和临床证据进行审查.
- 阐明ERα,ERβ和GPER1在性别特异性肺病理中的作用.
- 识别知识缺口和治疗创新的机会.
主要方法:
- 对肺部疾病中雌激素受体的现有机械和临床研究的综合.
- 分析受体亚型平衡,局部化和连接体背景,以确定雌激素信号输出结果.
- 对临床观察结果的审查,将雌激素信号与喘,慢性肺炎和其他呼吸系统疾病联系起来.
主要成果:
- 一般来说,ERβ通过保持矩阵完整性和减少炎症来促进肺部健康.
- ERα通常会加剧炎症,而GPER1则会调解免疫力和血管度的快速反应.
- 雌激素受体活性解释了喘和COPD易感性的性别差异.
结论:
- 雌激素受体信号传递的平衡和背景极大地决定了肺部的保护性或致病性影响.
- 了解这些途径可以解释呼吸道疾病的性别差异.
- 未来的研究应该专注于受体选择性连接体和精确呼吸治疗的性意识临床试验.
相关概念视频
01:31Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
418
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
418
01:08Intracellular Hormone Receptors
58.4K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
58.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
01:31Internal Receptors
74.0K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.0K